Global Venous Stents Market is expected to grow at a CAGR of 9.97% during the forecast period from 2018-2025
A new research report published by Fior Markets with the title Venous Stents Market by Technology (Iliac Vein Stents Technology, Wallstent Technology, Others), Application, Disease Indication, Regions, and Global Forecast 2018-2025.
As per the report, the global venous stents market is expected to grow from USD 798.38 Million in 2017 to USD 1,708.28 Million by 2025, at a CAGR of 9.97% during the forecast period from 2018-2025.
DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/386028/request-sample
Major players in the global venous stents market are Boston Scientific Corporation, C. R. Bard, Inc., Jotec GmBH, Veniti, Inc., Gore Medical, Cook Medical, Optimed Medizinische Instrumente GmBH, Medtronic, Medica Germany GMBH & Co. KG, Cardinal Health, Macromed, Genodynamic, among others. Major firms are increasingly focusing on the launching the newer innovative products. For instance C. R. Bard Inc in 2018, announced that it has received the US FDA approval for its Covera Vascular Covered Stent. The Covera Vascular Covered Stent is pre-mounted on a delivery catheter system. The device is intended for the treatment of narrowing (stenosis) or blockage of blood flow where the vein and arteriovenous (AV) access graft connect.
Technology segment is divided into iliac vein stent technology, wallstent technology and others. Owing to the properties of iliac venous stents for being flexible, possessing good radial force, MRI compatibility, and inexpensive, the Iliac vein stents technology led the global venous stents market with USD 571.08 million revenue in 2017. Wallstent technology segment is projected to grow at a steady pace over the forecast period. Application segment is categorized into legs, chest, abdomen and arm. Legs application segment emerged as the leader in the global venous stents market with USD 351.83 million revenue in 2017. This increased growth can be attributed to the factors such as increasing prevalence of the Deep Vein Thrombosis (DVT), increasing geriatric population. Growing preference for minimally invasive surgical procedures and growing incidence of chronic lung disease are factors that are anticipate to propel chest segment to grow at the highest CAGR of 11.76% over the forecast period. Disease Indication is segmented into chronic deep vein thrombosis (DVT), Post thrombotic syndrome (PTS), May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae, and others. Technological advancements in the treatment methods as well as rise in number of people suffering with DVT are the factors that are expected to boost chronic deep vein thrombosis segment to grow at a CAGR of 11.37% over the forecast period.
Even though factors such as increasing prevalence of chronic symptomatic venous diseases and chronic venous occlusion disorder as well as growing worldwide geriatric population are driving the global global venous stents market. The lack of awareness about venous interventional procedures and high treatment cost are expected to hamper the market growth.
About the report:
The global venous stents market is analysed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on firstname.lastname@example.org or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
- CDN Newswire